Cite
HARVARD Citation
Sassier, M. et al. (n.d.). Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world setting. Lung cancer. 89 (2), pp. 161-166. [Online].